Merck in collaboration with UCLPartners invites you to the standalone promotional webinar: ‘MS, Rethinking Tomorrow’ for Academic Health Science Networks (AHSNs) and the MS clinical community – developed by Merck in collaboration with the AAC Cladribine Working Group, led by UCLPartners on behalf of the AHSN Network.
In this promotional webinar we will explore the challenges in getting patients back on to DMT treatment during the COVID-19 pandemic and look at the role of cladribine tablets in appropriate patients. Each panelist will deliver a short presentation, followed by a facilitated Q&A on the issues discussed.
Dr Heather Wilson, Consultant Neurologist, National Hospital for Neurology and Neurosurgery, London
Dr Nikos Evangelou, Consultant Neurologist & Associate Clinical Professor, Nottingham University Hospital
Professor Jeremy Hobart, Consultant Neurologist, Plymouth Hospitals NHS Trust
This standalone promotional webinar is aimed at individuals within AHSNs who have an interest in MS services and the MS clinical community, including MS neurologists, MS nurses and pharmacists.
This promotional webinar has been initiated, organised and funded by Merck in collaboration with UCLPartners.